Clinical trial
Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea
NCT00036192 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00036192 |
|---|---|
| Title | Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma US, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | FK614 |
| Enrollment | 200 |
| Start date | Feb 1, 2002 |
| Completion | Mar 1, 2006 |
| First posted | May 9, 2002 |
| Last update posted | Dec 9, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: